Advertisement
How we create obstacles for sexual, reproductive and menopausal healthcare despite our best intentions
One approved non-hormonal therapy and another on the horizon reduce vasomotor symptoms
Investigative highlights include hormone therapies, biomarkers and early lifestyle interventions
Some post-menopausal patients may benefit from treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A look at how to asses hCG elevation
What is female hypoactive sexual desire disorder and how is it treated?
Holly L. Thacker, MD, weighs in
Advertisement
Advertisement